pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$TNDMTANDEM DIABETES CARE INC

$TNDM22.53-2.59%
San Diego, CA, USupdated 4h ago

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 5
  • druginsulin21 co-mentions · 7 sources
  • tagType 2 Diabetes10 co-mentions · 10 sources
  • tagAdCom5 co-mentions · 5 sources
  • tag510(k) Clearance5 co-mentions · 5 sources
  • tagRecall5 co-mentions · 5 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
53
approvals ytd
0
recalls ytd
1

Pipeline(0)

no pipeline products on record

📅 Upcoming

Nov 5, 2026
earnings
$TNDM22.53-2.59%
in 3mo
TANDEM DIABETES CARE INC earnings
TANDEM DIABETES CARE INC
→

🕒 Recent(90d)

earnings (2)
Aug 6, 2026
earnings
$TNDM22.53-2.59%
8d ago
TANDEM DIABETES CARE INC earnings
TANDEM DIABETES CARE INC
→
Aug 5, 2026
earnings
$TNDM22.53-2.59%
9d ago
TANDEM DIABETES CARE INC earnings
TANDEM DIABETES CARE INC
→
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Mar 17, 26SELLNovara Mark David· EVP & CHIEF COMMERCIAL OFFICER187 sh @ $23.05−$4K↗
  • Mar 5, 26SELLNovara Mark David· EVP & CHIEF COMMERCIAL OFFICER2 sh @ $22.81−$46↗
routine RSU / option mechanics (6)
  • Apr 15, 26tax coverKyrillos Jean-Claude · EVP & Chief Operating Officer1,926 sh
  • Apr 15, 26option exerciseKyrillos Jean-Claude · EVP & Chief Operating Officer3,636 sh
  • Apr 15, 26option exerciseKyrillos Jean-Claude · EVP & Chief Operating Officer3,636 sh
  • Mar 16, 26tax coverNovara Mark David · EVP & CHIEF COMMERCIAL OFFICER5,540 sh
  • Mar 16, 26option exerciseNovara Mark David · EVP & CHIEF COMMERCIAL OFFICER7,414 sh
  • Mar 16, 26option exerciseNovara Mark David · EVP & CHIEF COMMERCIAL OFFICER7,414 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
No open roles indexed yet — view TANDEM DIABETES CARE INC jobs →

News

no news has mentioned this company yet
identifiers
ticker
$TNDM
SEC CIK
0001438133
country
US
source
sec_tickers
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 3m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?